Look At Analyst Expectations For A Better Read On Arcus Biosciences Inc (NYSE: RCUS)
BlackRock Fund Advisors recently announced the acquisition of new stake in Arcus Biosciences Inc (NYSE:RCUS). The institutional investor has increased its shareholding in the Healthcare company by 0.08% to 8.34 million shares with purchase of 6884.0 shares. This fresh investment now brings its stake to 11.14% valued currently at $159.27 million. In addition, Fidelity Management […]